(Health-NewsWire.Net, August 02, 2018 ) The vascular grafts market is consolidated in nature, with a few key players dominating a majority of the market share. The major players in this market are B. Braun (US), C. R. Bard (US), Cardinal Health (US), Cook Medical (US), Endologix (US), LeMaitre Vascular (US), Medtronic (Ireland), Maquet (Germany), Terumo (Japan), and Gore Medical (US).
Browse 75 market data Tables and 31 Figures spread through 112 Pages and in-depth TOC on "Vascular Graft Market" https://www.marketsandmarkets.com/Market-Reports/vascular-graft-market-179457001.html
Most companies in the vascular grafts market adopted product launches and acquisitions as major growth strategies. Combined, these strategies accounted for the largest share of the overall growth strategies mapped from 2014 to 2017. Some of the leading players who adopted these strategies include Medtronic (Ireland), and Endologix (US).
Medtronic held the leading position in the vascular grafts market in 2016The company operates in the US and other developed countries, it also has a significant presence in emerging markets. The company adopted both organic and inorganic growth strategies to enhance its presence in this market. In July 2017, the company acquired Aptus Endosystems for USD 110 million to improve its distribution network. The company also focuses on innovation to address the needs of end users, in October 2017, Medtronic Endurant II/IIs, a thoracic stent graft system, received FDA approval to treat short neck Anatomies when used with Heli-FX EndoAnchor System
Request Sample Pages: https://www.marketsandmarkets.com/requestsample.asp?id=179457001
B. Braun held the second position in the vascular grafts market in 2016. The company has a broad product portfolio along with a strong brand image which helps the company to widen its customer base. The vascular graft products of the company are available across geographies.
Endologix held the third position in the vascular grafts market in 2016. The company manufactures innovative aortic disorder treatment devices. The company offers abdominal aortic aneurysm (AAA) products based on two platforms, namely, traditional minimally invasive EVAR and EVAS. The company adopted organic growth strategies to establish itself in this market. For instance, in January 2017, the company’s the CE Mark approval for the AFX and AFX 2 Endovascular AAA System was reinstated.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 sales@marketsandmarkets.com
MarketsandMarkets
Mr. Shelly Singh
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com
|